The aptamer market is experiencing significant growth, driven by an array of factors that enhance its appeal across various applications, including diagnostics, therapeutics, and research. Aptamers, which are short, single-stranded oligonucleotides that can selectively bind to specific targets, offer unique advantages over traditional antibodies. Their ability to be engineered for specificity,...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek